Molecular Profiling of Neurons Based on Connectivity  by Ekstrand, Mats I. et al.
ResourceMolecular Profiling of Neurons
Based on Connectivity
Mats I. Ekstrand,1,2 Alexander R. Nectow,1,2 Zachary A. Knight,1 Kaamashri N. Latcha,1 Lisa E. Pomeranz,1
and Jeffrey M. Friedman1,*
1Laboratory of Molecular Genetics, Howard Hughes Medical Institute, The Rockefeller University, 1230 York Avenue, New York,
NY 10065, USA
2Co-first authors
*Correspondence: friedj@rockefeller.edu
http://dx.doi.org/10.1016/j.cell.2014.03.059SUMMARY
The complexity and cellular heterogeneity of neural
circuitry presents a major challenge to understand-
ing the role of discrete neural populations in control-
ling behavior. While neuroanatomical methods
enable high-resolution mapping of neural circuitry,
these approaches do not allow systematic molecular
profiling of neurons based on their connectivity.
Here, we report the development of an approach
for molecularly profiling projective neurons. We
show that ribosomes can be tagged with a camelid
nanobody raised against GFP and that this system
can be engineered to selectively capture translating
mRNAs from neurons retrogradely labeled with
GFP. Using this system, we profiled neurons projec-
ting to the nucleus accumbens.We then used an AAV
to selectively profile midbrain dopamine neurons
projecting to the nucleus accumbens. By comparing
the capturedmRNAs from each experiment, we iden-
tified a number of markers specific to VTA dopami-
nergic projection neurons. The current method
provides ameans for profiling neurons based on their
projections.
INTRODUCTION
An important goal in neuroscience is to understand how neural
circuits control behavior. Toward this end, intensive efforts are
being made to delineate the complete wiring diagram, or con-
nectome, of the mammalian brain. High-throughput electron
microscopy has been used to define microscale connectivity
(Helmstaedter et al., 2013), while tracing strategies utilizing
virally encoded fluorophores have allowed for milliscale circuit
mapping (Wickersham et al., 2007), with postsynaptic cell-type
specificity in some cases (Wall et al., 2010; Wall et al., 2013).
While these studies have elegantly dissected a number of
complex circuits, they are not designed to provide molecular
information about the presynaptic neural populations. The iden-
tification of marker genes for neurons comprising circuits
enables testing of their functional role, which is key to under-
standing how the brain controls complex neural processes.1230 Cell 157, 1230–1242, May 22, 2014 ª2014 Elsevier Inc.Methods for identifying markers expressed in molecularly
defined neurons in the mammalian nervous system have been
developed by translationally profiling cells through the expres-
sion of a ribosomal tag (Heiman et al., 2008; Sanz et al., 2009).
Translating ribosome affinity purification (TRAP) can yieldmolec-
ular profiles of defined neural populations using cell-type-spe-
cific expression of a GFP-L10 fusion protein through bacterial
artificial chromosome (BAC) transgenesis or conditional expres-
sion of a floxed allele (Doyle et al., 2008; Stanley et al., 2013).
While providing detailed information about the molecular
identity of populations of neurons, TRAP does not provide neuro-
anatomical information. Given that the function of a defined pop-
ulation of neurons is inextricably linked to its circuit connectivity,
we sought to adapt TRAP technology to molecularly profile and
identify subsets of neurons that project into specific brain re-
gions. We focused first on the nucleus accumbens, which plays
an important role in diverse behaviors such as feeding, addic-
tion, and depression (Chaudhury et al., 2013; Lim et al., 2012;
Lu¨scher and Malenka, 2011; Tye et al., 2013).
To profile neurons based on their site of projection, we set out
to functionalize green fluorescent protein (GFP) (Tsien, 1998),
such that it could tag ribosomes and allow their precipitation in
a manner analogous to that of TRAP. Since GFP is commonly
encoded in retrograde tracing viruses, such as canine adeno-
virus type 2 (CAV; Bru et al., 2010), this approach would allow
us to precipitate ribosomes from only those neurons that project
to a defined region. To achieve this, we utilized camelid nano-
bodies, which are small, genetically encoded, intracellularly
stable and bind their antigens with high specificity and avidity
(Muyldermans, 2013). Camelid nanobodies have recently been
used in a number of applications, such as intracellular localiza-
tion of proteins (Ries et al., 2012), live-cell antigen targeting
(Rothbauer et al., 2006), and modulation of gene expression
(Tang et al., 2013).
We hypothesized that an anti-GFP nanobody fused to a ribo-
somal protein could stably bind GFP intracellularly and allow for
ribosome precipitation. Moreover, if used in combination with
GFP expressed from a retrograde tracing virus such as CAV-
GFP, this approach would allow for immunoprecipitation of
ribosomes specifically from projective neurons.
In the current work, we generated transgenic mice that
express an N-terminal fusion protein consisting of the VHH frag-
ment of a camelid antibody raised against GFP (Rothbauer et al.,
2006), fused to large ribosomal subunit protein Rpl10a (NBL10)
Figure 1. Neuron-Specific Expression of a Nanobody-L10 Fusion Protein
(A) Heterologous expression of an anti-GFP camelid nanobody fused to a ribosomal protein allows for immunoprecipitation of translating mRNAs in the presence
of GFP.
(B) Transgene used to generate SYN-NBL10 mice. A neuron-specific human synapsin promoter (SYN) drives the expression of an HA-tagged anti-GFP camelid
VHH domain (nanobody) fused to ribosomal protein L10a.
(C) Colocalization between HA-tagged NBL10 (green) and neuronal marker NeuN (red) in various brain regions. Dentate gyrus merge also displays Hoechst
staining to show the presence of HA-/NeuN- glial cell-types (white arrows).
Scale bars, 500 mm for amygdala and hippocampus, 250 mm for visual cortex, and 25 mm for dentate gyrus. See also Figure S1.under the control of the synapsin promoter. By injecting the retro-
gradely transported CAV-GFP virus (Bru et al., 2010) into the
nucleus accumbens shell, we were able to capture ribosomes
from presynaptic neurons in the ventral midbrain and hypothala-
mus, and identify markers delineating cell-types that project to
this region. Furthermore, using a Cre-conditional AAV encoding
the NBL10 fusion, we were able to molecularly profile VTA dopa-
mine neurons projecting to the nucleus accumbens. This work
provides a general means for molecularly profiling presynaptic
cell-types based on their projection pattern, and identifies
marker genes for neuronal populations that are potentially rele-
vant to a variety of behaviors including feeding, and neuropsychi-
atric diseases, such as addiction and depression.
RESULTS
Generation of SYN-NBL10 Transgenic Mice
GFP is commonly used to visualize restricted subsets of neurons
within the brain, but means for directly profiling these neurons
are limited (Sugino et al., 2006). In order to profile neurons ex-
pressing GFP, we first set out to tag ribosomes with a camelidnanobody raised against GFP (Figure 1A). Previous work has
demonstrated that it is possible to create N-terminal fusions of
the large ribosomal subunit protein Rpl10a with small epitope
tags such as GFP that do not interfere with ribosome function
(Heiman et al., 2008). We thus generated a transgenic mouse
that expresses an anti-GFP nanobody fused to the N terminus
of ribosomal subunit protein Rpl10a (NBL10) under the control
of the neuron-specific human synapsin promoter (hereafter
SYN-NBL10). In addition, we engineered the NBL10 fusion
protein with an HA tag, allowing us to visualize the sites of
expression using immunohistochemistry (Figure 1B).
To confirm that expression of the NBL10 transgene was
neuron-specific, we performed immunohistochemistry for HA
and NeuN, a commonly used neuronal marker (Figure 1C). We
then counted more than 4,000 cells (n = 3 mice) and found
only 4 cells that were not double-labeled, demonstrating that
NBL10 expression is neuron-specific in these mice (Figure S1
available online). Moreover, upon counterstaining with Hoechst
to mark all nuclei in the brain, we found large numbers of HA-/
NeuN- cells, further indicating that NBL10 is not expressed in
nonneuronal cell-types (Figure 1C, white arrows).Cell 157, 1230–1242, May 22, 2014 ª2014 Elsevier Inc. 1231
Figure 2. Optimization of Immunoprecipitation for GFP
(A) Schematic of immunoprecipitation with beads with and without GFP.
(B) Quantification of RNA yield after immunoprecipitation from SYN-NBL10 mice using GFP-coated or uncoated magnetic beads (p < 0.01).
(C) Bioanalyzer trace of immunoprecipitated RNA with and without GFP. FU, fluorescence units.
(D) Taqman analysis of neuronal and glial marker genes in RNA immunoprecipitated with recombinant GFP (p < 0.0001 for glial markers).
(E) Mixing experiment illustration. CAV-GFP is injected into a SYN-NBL10 (gray background) or wild-type (white background) mouse. Injected brains are
homogenized together with a noninjected brain of the complementary genotype to assay GFP-nanobody binding in lysates during the IP.
(F) RNA yield after immunoprecipitation of mixed lysates with no recombinant nanobody (rNB) added to the homogenization buffer.
(G) GFP enrichment in IP RNA from SYN-NBL10 mice injected with CAV-GFP. Data are plotted as GFP fold enrichment (IP/Input) against buffer rNB
concentration.
(H) RNA yield after immunoprecipitation of mixed lysates with 100 ng/ml rNB in the buffer.
Data are presented as mean ± SEM. See also Figure S2.Nanobody-Tagged Ribosomes Can Be Precipitated
Using GFP
We next set out to selectively immunoprecipitate (IP) neuronal
ribosomes from SYN-NBL10 transgenic mice using GFP. Mag-
netic beads were coated with anti-GFP monoclonal antibodies
that bind different epitopes on GFP than the one recognized by
the nanobody. We then compared the ability of beads loaded
with recombinant GFP versus control beads to immunoprecipi-
tate ribosomes from whole-brain lysate of SYN-NBL10 trans-
genic mice (Figure 2A). In our immunoprecipitate, we obtained
yields of 2.0 ng/ml RNA for GFP-loaded beads and 0.004 ng/ml
RNA for control beads (p < 0.01; Figure 2B). Similarly, 18S and
28S rRNA peaks were only detected in IPs using GFP-coated
beads demonstrating that GFP is required for immunoprecipita-
tion of RNA (Figure 2C). If the IP is specific to neuronal ribo-
somes, we would also expect to substantially deplete for glial
markers, while not depleting for neuronal markers in the precip-
itated RNA. We found that RNA for all tested glial markers were
indeed depleted in the IP relative to total (Input) RNA:Gfap (38.8-
fold), Mal (49.1-fold), and Mbp (55.1-fold) (p < 0.0001 for all
genes; Figure 2D). As expected, the neuronal markers Kcc2,
Nefl, and Snap25, were present in similar amounts in the IP rela-
tive to Input RNA. All enrichments were determined by dividing IP
over Input values for each gene after normalization to Rpl23.1232 Cell 157, 1230–1242, May 22, 2014 ª2014 Elsevier Inc.These experiments confirmed that nanobody-tagged neuronal
ribosomes can be selectively immunoprecipitated from SYN-
NBL10 transgenic mice in the presence of GFP, while immuno-
precipitation of glial ribosomes is markedly reduced.
Selective Immunoprecipitation of Ribosomes Bound to
Virally Encoded GFP
The finding that GFP can be used to immunoprecipitate NBL10-
decorated ribosomes suggested that this approach could be
used to precipitate ribosomes after infection of neurons with a
virus expressing GFP. Canine adenovirus expressing GFP
(CAV-GFP) was injected bilaterally into the nucleus accumbens
(Figure S2A), and the region surrounding the injection site was
dissected. Immunohistological staining revealed that thevastma-
jority of cells that were infected were neurons (Figure S2D). We
then lysed tissue from the infected region and performed a GFP
IP (Figure S2B). Consistent with the previous data, glial markers
were depleted: Gfap (11.1-fold), Mal (14.8-fold), and Mbp (21.2-
fold). In addition, Gfp was enriched (11.5-fold; Figure S2C). To
test the possibility that GFP enrichment might be artificially
increased by directly pulling down the nascent translating strand,
we infected Hepa 1-6 cells with CAV-GFP (Figure S2E) and per-
formed IPs. In this case, we were not able to detect any RNA in
our IPs (FiguresS2FandS2G), demonstrating that nascent strand
contamination of our IPs is negligible. Additionally, we observed
no substantial alterations in endogenousgene expression relative
to mock infected cells, further confirming that CAV-GFP is a suit-
able virus for translational profiling (Figure S2H).
However, since only virally infected cells should express GFP
mRNA, we had expected to obtain a substantially higher enrich-
ment for GFP above the 11.5-fold that was observed. We thus
considered the possibility that Gfp enrichment might be lower
than expected due to viral overexpression of GFP. Excess GFP
would likely have a high stoichiometry relative to the NBL10
fusion protein, in which case there might not be enough nano-
body to sequester all soluble GFP protein in infected cells, lead-
ing to GFP spillover in the lysate. Spillover would potentially
cause promiscuous GFP binding to free NBL10-labeled ribo-
somes from nearby but uninfected neurons. This would, in
turn, lead to a decrease in the relative amount of GFP RNA in
our IPs and consequently reduce enrichment of GFP RNA as
well as other mRNAs expressed in the infected neurons. We ad-
dressed this possibility by designing a mixing experiment to test
whether GFP spillover was a significant source of background.
The mixing experiment was designed to assess the extent to
which excess GFP could bind to nanobody-tagged ribosomes
after tissue homogenization. In a first experiment, tissue from
wild-type (WT) mice infected with CAV-GFP was combined
with tissue from uninfected SYN-NBL10 transgenic mice and
homogenized together (hereafter group B; Figure 2E, right). If
RNA was precipitated after incubation of the mixed lysate with
magnetic beads coated with anti-GFP antibodies, it would
confirm that free GFP was binding to nanobody-labeled ribo-
somes after tissue homogenization. The data were compared
to that in which tissue from CAV-GFP-infected SYN-NBL10
transgenic mice was mixed with tissue from WT mice (group A;
Figure 2E, left). We found that equivalent amounts of RNA
were precipitated in groups A and B thus confirming that free
GFP can bind to nanobody-labeled ribosomes in the lysate (Fig-
ure 2F). This suggested that a robust experiment would require
the elimination of this binding.
We reasoned that by adding recombinant nanobody (rNB) to
the lysate, we could sequester free GFP and render it unavailable
for binding to the NBL10 fusion protein. This would reduce the
background in our immunoprecipitate and thus augment GFP
enrichment. To test this, we analyzed the fold enrichment for
GFP RNA in immunoprecipitations from brains of CAV-GFP-
infected SYN-NBL10 mice in the presence of increasing
amounts of rNB in the homogenization buffer. We found that
the addition of rNB markedly increased the fold enrichment for
GFP RNA to more than 41-fold, compared to the previously
observed 11.5-fold enrichment without the addition of rNB (Fig-
ure 2G). We also found that the increased enrichment of GFP
RNA was near maximal at 100 ng/ml of added rNB (Figure 2G).
We then repeated the mixing experiment described above,
now adding 100 ng/ml of rNB prior to tissue homogenization.
In this case, substantially more RNA was recovered from group
A (14 ng/ml), as compared to group B (1.7 ng/ml; Figure 2H).
These data demonstrate that the addition of 100 ng/ml of free
rNB is sufficient to reduce promiscuous binding of GFP to ribo-
somes from uninfected neurons, while also maximizing the
enrichment of GFP. Thus, the addition of recombinant nanobodyprior to tissue homogenization greatly improves the specificity of
the GFP immunoprecipitation.
Translational Profiling of Neurons Projecting to the
Nucleus Accumbens
The previous experiments demonstrated that we are able to
immunoprecipitate ribosomes specifically from CAV-GFP-
infected neurons in SYN-NBL10 transgenic mice. We next set
out to molecularly profile neurons that project from one region
to another by exploiting the retrograde transport of CAV-GFP
from nerve terminals to soma. This virus is replication deficient,
so when it reaches the soma of the presynaptic neuron, it is
incapable of traversing synapses and will not infect any other
upstream neurons. Thus by infecting nerve terminals with CAV-
GFP in SYN-NBL10 transgenic mice, ribosomes in the soma
will be labeled with GFP. We next assessed whether we could
isolate ribosomes and mRNA from neurons that project into
the nucleus accumbens (NAc).
The nucleus accumbens integrates inputs from diverse re-
gions throughout the brain, including the raphe nuclei in the
brainstem, the medial prefrontal cortex, and hippocampus.
Additionally, the NAc receives heavy input from dopaminergic
neurons of the ventral tegmental area (VTA), as well as inputs
from melanin-concentrating hormone (MCH) neurons of the
lateral hypothalamus (LH; Georgescu et al., 2005). These popu-
lations are known to play important roles in reward-related
behaviors and feeding, respectively. We were especially
interested in these circuits because dysfunction of the NAc can
contribute to a variety of disorders, such as obesity, addiction,
and depression. Importantly, the VTA and LH inputs are anatom-
ically segregated (i.e., sufficiently distant) from the accumbens
shell, making it possible to dissect the brain regions from which
these presynaptic populations originate without contaminating
our IP with CAV-GFP-infected neurons at the site of injection
(Figure 3A). While subsets of MCH neurons of the LH and dopa-
minergic neurons of the VTA project to regions other than the
NAc, the current methodology would allow us to selectively pro-
file only the subpopulations of MCH and DA neurons that project
directly to the accumbens shell. Neurons that do not project to
the NAc will not express GFP, and their ribosomes will therefore
not be precipitated (Figure 3B).
We injected mice with CAV-GFP in the nucleus accumbens
and mapped the regions that were labeled with GFP to visualize
neurons that project to the NAc. We observed a large number of
GFP-positive neurons throughout the midbrain and hypothala-
mus (Figure 3C), as well as in themedial prefrontal cortex, amyg-
dala, hippocampus, and dorsal raphe nucleus (Figure S3).
Consistent with previous reports (Lammel et al., 2011), we also
found that the majority of VTA neurons retrogradely labeled
from the nucleus accumbens expressed tyrosine hydroxylase
(TH; Figure 3D), a marker for dopaminergic neurons. We
observed substantial numbers of GFP-positive neurons in the
hypothalamus and confirmed that GFP colocalized with MCH
in a subset of neurons in the LH (Figure 3E).
To purify ribosomes from neurons projecting to the NAc, we
dissected a 3 mm piece of tissue distant from the site of injection
that included the hypothalamus and the midbrain after bilateral
injections of CAV-GFP in the NAc of SYN-NBL10 mice. WeCell 157, 1230–1242, May 22, 2014 ª2014 Elsevier Inc. 1233
Figure 3. Projection-Specific Translational Profiling after CAV-GFP Injections into Nucleus Accumbens
(A) CAV-GFP injected into the nucleus accumbens is retrogradely transported to brain regions that send projections to the injection site. Only projective neurons
will express GFP, as the virus is unable to replicate or cross synapses. Dashed red box indicates dissection for immunoprecipitation.
(B) Infected neurons contain GFPmRNA and protein (green circles) that can bind nanobody-tagged (red) ribosomes. Interspersed uninfected cells will not contain
GFP mRNA or protein.
(C) Sagittal image showing retrograde spread of CAV-GFP through the hypothalamus and ventral midbrain.
(D) Colocalization between GFP and TH in the ventral midbrain.
(E) Colocalization between GFP and MCH in the lateral hypothalamus. White arrows indicate double-positive cells.
(F) qPCR for GFP and glial transcripts after IP (p < 0.05 for all genes). Data are expressed as fold enrichment (IP RNA/Input RNA).
(G and H) qPCR results for tyrosine hydroxylase (p < 0.001) and pro-melanin-concentrating hormone (p < 0.05) transcripts.
Scale bars, 500 mm in (C), 250 mm in (D), and 100 mm in (E). qPCR data are normalized to Rpl23 expression. Data are presented as mean ± SEM. See also
Figure S3.performed GFP IPs in the presence of 100 ng/ml rNB (Figure 3A,
red dashed box). We observed highly significant enrichment for
Gfp RNA (96.4-fold), while depleting for all glial markers tested:
Gfap (6.7-fold), Mal (8.7-fold), and Mbp (18.8-fold) (p < 0.05 for
all genes; Figure 3F). Importantly, we found significant enrich-
ment for Th RNA (8.7-fold, p < 0.001; Figure 3G) and Pmch
RNA (6.7-fold, p < 0.05; Figure 3H). These data validate that
the current method can identify marker genes for neurons that
project to the NAc.
Identification of Marker Genes for Neurons Projecting
to the Nucleus Accumbens
Dopaminergic neurons of the VTA (Sesack and Grace, 2010) and
MCH neurons of the LH (Georgescu et al., 2005) are known to
project to the nucleus accumbens. However, the molecular pro-
file of the specific subsets of these neurons that project to the
NAc has not been explored, nor have markers for additional neu-
ral populations that project to this region been systematically
identified. To address this, we performed high-throughput RNA1234 Cell 157, 1230–1242, May 22, 2014 ª2014 Elsevier Inc.sequencing (RNA-seq) on the IP RNA, as well as on the Input
RNA from the midbrain and hypothalamus after injection of
CAV-GFP into the NAc of SYN-NBL10 mice (Figures 4A and
4B). The total number of mapped reads was similar between
the Input and IP RNA samples. Analysis of the sequencing
data showed significant enrichment (IP/Input) of greater than
100-fold for GFP (Figure 4A), suggesting that the IP was highly
specific for CAV-GFP-infected neurons that project from the
dissected region to the NAc.
We plotted the IP RNA and Input RNA FPKM (fragment per
kilobase of transcript per million mapped reads) values on a
log-log scale (Figure 4C). The top 75 genes that were enriched
in the IP RNA samples after RNA-seq analysis are also listed in
Table S1. As seen previously with qPCR, RNA-seq data showed
enrichment for Pmch (6.9-fold), as well as Tacr3 (6.5-fold) and
Cartpt (5.1-fold), and transcription factors Foxa1 (5.7-fold) and
Foxa2 (4.9-fold). All of these genes have been reported to be
coexpressed in MCH neurons (Croizier et al., 2010; Knight
et al., 2012; Silva et al., 2009).
Figure 4. Identification of Differentially
Expressed Marker Genes by RNA-Seq
(A) RNA-seq analysis of total reads mapped to the
mouse genome (black) and EGFP-coding
sequence (green) plotted on a linear scale.
(B) Histogram display of number of differentially
enriched genes (IP/Input).
(C) FPKM GFP IP plotted against FPKM Input on a
log-log scale. Outer lines are 2-fold enriched/
depleted genes. A subset of differentially enriched
marker genes are highlighted. Red dots indicate
genes that are significantly different (q < 0.05) in
Input versus IP. Blue dots indicate nonsignificant
genes.
See also Table S1 and Figure S4.Similarly, marker genes coexpressed with Th (11.4-fold
enriched) in dopaminergic neurons of the ventral midbrain were
also enriched including, Slc6a3 (7.8-fold), Ddc (5.2-fold), and
Nurr1 (5.2-fold), as well as a-synuclein (Snca, 4.9-fold; Mosharov
et al., 2009). These genes were then reconfirmed with qPCR:
Slc6a3 (10.1-fold, p < 0.05), Ddc (5.7-fold, p < 0.01), Nurr1 (2.8-
fold, p < 0.01), and Snca (4.6-fold, p < 0.01). Another subset of
highly enriched genes not commonly associated with midbrain
dopamine neurons, such as Anxa1, Calb2, Chrna6, Gch1, Grp,
andSlc10a4were further analyzedby qPCR, andpairedwith their
AllenBrainAtlasexpressionprofiles (FigureS4A; Lein et al., 2007).
These data confirmed their expression in the ventralmidbrain and
further validate the ability of this approach to identify transcripts
expressed in specific subsets of projection neurons.
We also found differential expression of the neurotensin re-
ceptor isoforms Ntsr1 and Ntsr2, with significant enrichment of
Ntsr1 (6.1-fold) and depletion of Ntsr2 (7.4-fold) in the immuno-Cell 157, 1230–12precipitated RNA. Ntsr1 has been shown
previously to play an important role in
signaling from the LH to the VTA as part
of a reward circuit (Kempadoo et al.,
2013). The expression of these isoforms
was confirmed by qPCR, with Ntsr1 en-
riched 5.4-fold (p < 0.01) and Ntsr2
depleted 8.3-fold (p < 0.05; Figure S4C).
RNAs for numerous additional genes
were significantly enriched in the IP RNA
and many of these genes are likely to be
markers for populations of neurons pro-
jecting to the NAc (Figure S4B). Impor-
tantly, when we tested the effect of
CAV-GFP infection on expression of a
subset of identified marker genes in tis-
sue culture, no substantial alterations
were observed (Figure S4D).
Identification of Novel Projection
Markers
In our analysis of the RNA-seq data, we
observed that a subclass of S100A genes
(seven out of eight) were substantially
depleted from our immunoprecipitation.However, S100a10 was significantly enriched (2.1-fold; Fig-
ure 5A), and this was confirmed by qPCR (2.1-fold, p < 0.01; Fig-
ure 5B). S100a10 expression was not significantly altered by
infection with CAV-GFP in vitro (Figure S4D). S100a10, also
known as p11, is known to interact with serotonin receptors
and has been causally implicated in depressive disorders (Sven-
ningsson et al., 2006). Indeed, p11-containing cortical projection
neurons have recently been identified as being responsible for
mediating the response to antidepressants (Schmidt et al.,
2012); however, data suggesting a possible role for p11 neurons
projecting from hypothalamus to NAc are lacking.
To validate the finding that hypothalamic neurons expressing
p11 project to the NAc using a different neural tracer, we gener-
ated a replication-deficient pseudorabies virus expressing
mCherry (PRV-mCherry). PRV is another well-characterized
virus that is retrogradely transported after injection, and similar
to CAV-GFP, this strain is incapable of traversing synapses.42, May 22, 2014 ª2014 Elsevier Inc. 1235
Figure 5. A Subset of Hypothalamic Projection
Neurons Express p11
(A) Differential enrichment (IP/Input) of the S100A family
of genes in neurons projecting to the nucleus
accumbens assessed by RNA-seq, on a Log2 scale.
Actin (Actb) is shown for reference.
(B) qPCR confirmation of S100a10 (p11) enrichment
(p < 0.01).
(C) Colocalization between p11-EGFP and PRV-
mCherry in the lateral hypothalamus.
(D) Top: colocalization between p11-EGFP and
MCH. Bottom: colocalization between p11-EGFP and
hypocretin.
(E) Colocalization between p11-EGFP, PRV-mCherry,
and hypocretin. White arrows indicate triple-stained
cells. Gray arrows indicate p11-positive projection
neurons that do not colocalize with hypocretin.
qPCR data are normalized to Rpl23. Data are presented
as mean ± SEM. All scale bars, 100 mm. See also
Figure S5.
1236 Cell 157, 1230–1242, May 22, 2014 ª2014 Elsevier Inc.
Figure 6. Molecular Profiling of VTA Dopamine Neurons Projecting to the Nucleus Accumbens
(A) AAV-FLEX-NBL10 construct developed to conditionally express NBL10 in the presence of Cre recombinase.
(B) AAV-FLEX-NBL10 is injected into the VTA and CAV-GFP into the NAc of DAT-IRES-Cre mice. NBL10 is restricted to VTA dopamine neurons, and CAV-GFP to
NAc-projecting neurons. Only ribosomes from double-labeled cells (VTA dopamine neurons projecting to the NAc) can be immunoprecipitated.
(C) Colocalization between NBL10, GFP (from CAV), and TH in the VTA.
(D) qPCR after cell-type-/projection-specific IPs. Data are expressed as fold enrichment (IP RNA/Input RNA). ND means that IP RNA is not detected.
(E) Enriched marker genes from (D) labeled using FISH. Colocalization between enriched genes, GFP (from CAV), and TH.
(F) Colocalization between Relaxin 3 and TH.
qPCR data are normalized to Rpl23. Scale bars, (top) 500 mm and (bottom) 25 mm in (C), and 50 mm for (E). White arrows in (C) and (E) indicate triple-stained cells.We injected PRV-mCherry bilaterally into the nucleus accum-
bens of p11-EGFP transgenic mice (Oh et al., 2013) and
observed substantial overlap between cells expressing p11
(EGFP) and mCherry in the lateral hypothalamus (Figure 5C),
confirming these neurons project to the NAc.
We additionally wanted to know if there was any overlap
between the p11 projection neurons and other markers for
cell-types in the lateral hypothalamus that project to the NAc.Costaining for MCH and p11-EGFP revealed clear anatomical
segregation between the two cell-types (Figure 5D, top). Further-
more, we were not able to colocalize p11 and MCH in any neu-
rons of the p11-EGFP mouse. These data suggest that the p11
neurons in the LH that project to the NAc comprise a subset of
LH neurons distinct from MCH neurons. We noted, however, in
the RNA-seq data that therewas significant enrichment for hypo-
cretin RNA (9.6-fold; Table S1). Hypocretin expression defines aCell 157, 1230–1242, May 22, 2014 ª2014 Elsevier Inc. 1237
distinct subpopulation of lateral hypothalamic neurons that does
not overlap with MCH neurons. We thus performed immunohis-
tochemistry for p11 and hypocretin and observed significant
overlap and cellular colocalization between the two cell-types
(Figure 5D, bottom). We found that p11 was expressed in three
different regions of the hypothalamus (the arcuate nucleus, LH,
and paraventricular hypothalamus), and overlaps substantially
with hypocretin in the LH (Figure S5A). The overlap between
p11 and hypocretin in the LH ranged between 39%–52%, de-
pending on the relative position along the AP axis (Figure S5B).
We then injected PRV-mCherry into the nucleus accumbens of
p11-EGFP mice and costained for hypocretin. Triple staining for
GFP, mCherry, and hypocretin revealed that p11 neurons pro-
jecting to the nucleus accumbens partially overlap with the LH
hypocretin neurons (Figure 5E). Overall, this study identifies a
subpopulation of p11 neurons in the LH that project to the
NAc, and demonstrates that most but not all of these projection
neurons coexpress hypocretin.
Molecular Profiling of VTA Dopamine Neurons
Projecting to Nucleus Accumbens
In our earlier studies, we identified a number of markers that are
expressed in ventral midbrain neurons projecting to the nucleus
accumbens (see Figure S4). The data did not distinguish whether
these markers were expressed in dopaminergic neurons of the
VTA or in a different population. To test whether these markers
are expressed in VTA dopamine neurons projecting to the
nucleus accumbens, we set out to extend the current approach
to make it cell-type-specific. To accomplish this, we took advan-
tage of the fact that our technique utilizes a two-component
system; namely, both GFP and NBL10 are required to immuno-
precipitate RNA from a given cell. Furthermore, the NBL10
construct is relatively small (1 kb), which makes it amenable
to cloning into a Cre-dependent (FLEXed) AAV (Atasoy et al.,
2008). We thus cloned the Nanobody-L10 fusion protein
(NBL10) into a Cre-conditional AAV (AAV-FLEX-NBL10; Fig-
ure 6A). We then injected CAV-GFP into the nucleus accumbens,
and AAV-FLEX-NBL10 into the VTA of DAT-IRES-Cre mice (Fig-
ure 6B; Ba¨ckman et al., 2006). Immunohistochemistry against
NBL10 and TH demonstrated that NBL10 expression was
restricted to midbrain dopamine neurons. Furthermore, we
noted that a subset of these neurons were also labeled with
GFP, confirming that we had targeted a substantial number of
VTA dopamine neurons that project to the NAc (Figure 6C).
To purify ribosomes from only those VTA dopamine neurons
that project to the NAc, we dissected a 2 mm piece of tissue
that included the midbrain and performed IPs as described
above. In this case, we precipitated RNA only from VTA dopa-
mine neurons that project to the NAc, as only they will express
both GFP and NBL10. Importantly, ribosomes from cells ex-
pressing only GFP (nondopamine neurons that project to the
NAc) or only NBL10 (VTA dopamine neurons that do not project
to the NAc) will not be precipitated, as both components are
required. We substantially enriched for midbrain dopamine
markers including Slc6a3 (5.7-fold) and Th (7.2-fold), while
depleting for nondopaminergic marker genes Hcrt (IP RNA did
not amplify) and Slc6a4 (2.6-fold), as well as glial markers Gfap
(9.5-fold), Mal (13.3-fold), and Mbp (36-fold) (Figure 6D).1238 Cell 157, 1230–1242, May 22, 2014 ª2014 Elsevier Inc.A number of genes identified by our RNA-seq study are ex-
pressed in the ventral midbrain (see Allen Brain Atlas and Fig-
ure S4), suggesting that these are markers for VTA dopamine
neurons projecting to the nucleus accumbens. We assessed
the enrichment of seven of these different marker genes by
qPCR. Six of the genes were substantially enriched: Anxa1
(8.2-fold), Calb2 (2.3-fold), Grp (5.6-fold), Ntsr1 (6.1-fold),
Slc10a4 (7.1-fold), and Snca (5.2-fold) (Figure 6D). To further
validate that the enriched subset of genes are expressed in
VTA dopamine neurons projecting to the NAc, we injected
the NAc with CAV-GFP. We then performed fluorescence
in situ hybridization (FISH) against each one of these marker
genes in tandem with immunohistochemistry against GFP
and TH (Figure 6E). In each case, we observed substantial
numbers of triple-labeled cells (white arrows), confirming that
we were able to profile projective VTA dopamine neurons. Of
note, previous studies have shown expression of Grp in
midbrain dopamine neurons (Chung et al., 2005), though local-
ization to the nucleus accumbens-projecting dopamine neu-
rons has not been demonstrated. Conversely, we did not
enrich for relaxin-3 (Rln3), which was identified in the RNA-
seq study (Figure 6D). Upon costaining for relaxin-3 mRNA
and TH, we found that this marker was not expressed in
midbrain dopamine neurons, but rather in a discrete population
dorsal to the posterior substantia nigra (Figure 6F). Thus, by
systematically comparing data generated using AAV-FLEX-
NBL10 to the region-specific approach, we were able to iden-
tify markers for VTA dopamine neurons, as well as markers for
nondopaminergic cell-types.
DISCUSSION
Numerous studies have focused on the comprehensive, high-
resolution mapping of the connectivity within the central nervous
system (Helmstaedter et al., 2013; Maisak et al., 2013; Takemura
et al., 2013). This work, along with studies dating back to the
mid-1980s elucidating the connectome of the nematode
C. elegans (White et al., 1986), have worked toward the impor-
tant goal of relating neural structure to its function (Lichtman
and Denk, 2011; Morgan and Lichtman, 2013). However, con-
nectomic information is necessary but not sufficient to charac-
terize the role of neural populations within a functioning circuit,
in part because neural circuitry is labile to neuromodulation,
which is essential to its function but invisible to neuroanatomical
reconstruction (Bargmann, 2012). Thus, to understand how
neural circuits give rise to behavior, the synthesis of connec-
tomic and molecular information is essential.
The identification of markers for specific neurons enables an
array of studies delineating their function through use of electro-
physiology, molecular profiling, and neural activation/inhibition
using optogenetics or chemical genetics (Armbruster et al.,
2007; Boyden et al., 2005). Recently, translational profiling
approaches have made it possible to profile neurons based on
the expression of cell-type-specific marker genes (Heiman
et al., 2008), as well as changes in their activity (Knight et al.,
2012); however, these approaches do not provide neuroanatom-
ical information about the neurons being profiled. Thus, means
for simultaneously generating connectomic and molecular
information would help advance our understanding of how
neural circuits give rise to behavior.
Projection-Specific Translational Profiling
GFP is commonly encoded in retrograde tracing viruses to
identify presynaptic inputs to a defined locus within the brain.
However, while GFP expression can be used to confirm a neuro-
anatomical connection, it does not reveal the molecular compo-
sition of the cell-type. Additionally, many of the retrograde
viruses used, such as rabies virus, are often acutely toxic to the
cells they infect, potentially altering transcriptomic profiles (Osa-
kada and Callaway, 2013; Wickersham et al., 2007). To enable
molecular profiling of a presynaptic cell-type, we required an effi-
cient retrograde virus expressingGFP that hadminimal toxicity to
the infected cells. Canine adenovirus (CAV) had previously been
used for restoration of nigrostriatal dopamine release in a model
of dopamine deficiency, demonstrating the long-term preserva-
tion of neural function (Hnasko et al., 2006). In this report, we
used CAV-GFP to label the soma of projection neurons in which
ribosomes were tagged with an anti-GFP nanobody.
We focused our efforts on inputs to the nucleus accumbens
(NAc), as they are known to play an important role in such diverse
behaviors as feeding (Georgescu et al., 2005), social interaction
(Do¨len et al., 2013), and reward processing (Lammel et al., 2012).
Dysfunction of these neural populations is also implicated in a
variety of disease states, such as obesity (Ludwig et al., 2001),
addiction (Lu¨scher and Malenka, 2011), and depression (Chaud-
hury et al., 2013; Tye et al., 2013).
This work additionally enables the molecular definition of
anatomically interspersed populations of neurons within the
brain based on their projection pattern. The VTA, for example,
is a heterogeneous nucleus with distinct subsets of dopami-
nergic neurons that can be classified based on their projections
to a number of postsynaptic targets such as themedial prefrontal
cortex, nucleus accumbens, and hippocampus. However, these
populations are not dissociable by manual dissection, making
the profiling of these distinct neuronal populations impossible
using established techniques such as bacTRAP and RiboTag.
Thus, it is likely that molecular profiling of genetically defined
projective cell-types will be an important application of projec-
tion-specific translational profiling. Indeed, it is already
becoming clear that different projections from a molecularly
defined nucleus can have differential behavioral effects relevant
to reward processing (Lammel et al., 2012), as well as depres-
sion (Chaudhury et al., 2013). Toward this end, we extended
the current approach to profile VTA dopamine neurons projec-
ting to the nucleus accumbens using CAV-GFP, and a Cre-driver
line with an AAV that we generated.
The data reported here further indicate that NBL10 could be
incorporated into other vector systems for a variety of studies.
For example, a monosynaptic rabies virus expressing GFP could
be used in tandem with the SYN-NBL10 mouse (crossed to a
Cre-driver line) to profile neurons synapsing onto a molecularly
defined postsynaptic target (see Wall et al., 2013). Similarly,
this system could be adapted to identify markers for neurons
postsynaptic to genetically defined cells using Cre-dependent
anterograde strains of herpes simplex virus (Lo and Anderson,
2011).Molecularly profiling neurons based on their pattern of con-
nectivity represents a methodology that is conceptually distinct
from a number of recent efforts, which have beenmade to obtain
molecular genetic information from connectomic-based experi-
ments. Approaches such as single-synapse proteomic analysis
(Micheva et al., 2010) and the Allen Brain Institute’s cell-type-
specific, virally targeted expression of GFP (connectivity.
brain-map.org) have made significant progress in this area;
however, these methodologies require either highly sensitive
microscopy methods or numbers of transgenic mouse lines ex-
pressing Cre recombinase. Additionally, these approaches
require an a priori defined cell-type to be targeted. Thus, an un-
biased approach to studying molecular connectivity within the
brain as reported here should be of general use.
Alternate strategies have also been employed to molecularly
profile neurons based on their projection pattern, particularly
within the VTA. However, these approaches such as laser
capture microdissection (Lammel et al., 2008; Li et al., 2013)
have low RNA yields, require specialized instrumentation and
are difficult to implement, and are therefore not amenable to
high-throughput analyses. Another possible approach to pro-
jection-specific molecular profiling would be through fluores-
cence-activated cell sorting (FACS) of retrogradely-labeled,
fluorophore-positive neurons (see Sugino et al., 2006); how-
ever, the current isolation protocols for neuronal FACS (Lobo
et al., 2006) appear to induce cellular stress, and the resulting
molecular profiles have reduced sensitivity in comparison to
techniques like bacTRAP. Projection-specific translational
profiling using TRAP-based methodologies, therefore, allows
for access to translating mRNAs with high efficiency, enabling
detailed molecular analyses using quantitative PCR and
RNA-seq.Intersectional Genetic Applications of NBL10-Based
TRAP
The NBL10-based approach could be engineered to further
molecularly refine subpopulations of neural cell-types defined
by the intersection of two markers. For example, to translation-
ally profile a neural cell-type defined by two marker genes
(e.g., genes A and B), one could drive expression of NBL10 on
the gene A promoter, and cross this mouse to a gene B-GFP
mouse. This particular approachwould allow for increasing gran-
ularity in the systematic analysis of CNS cell-types that are
currently characterized by a single marker gene. Furthermore,
AAV-FLEX-NBL10 could be used for this purpose, as well. A
GFP line could be crossed to a partially overlapping Cre-driver
line, and the offspring could be injected with AAV-FLEX-NBL10
to profile the intersection of these two cell types. The data re-
ported here indicate that this approach is feasible and would
potentially enable an intersectional strategy for molecular
profiling of neurons allowing a further refinement of the analysis
of a variety of neuronal subpopulations.EXPERIMENTAL PROCEDURES
Animals
All experiments performed were approved by the Rockefeller University
Institutional Animal Care and Use Committee and were in accordance withCell 157, 1230–1242, May 22, 2014 ª2014 Elsevier Inc. 1239
the National Institutes of Health guidelines. SYN-NBL10 mice were generated
and maintained at Rockefeller University. A fragment encoding the Nanobody-
L10 fusion was synthesized and cloned into pSynAmp to generate pSynAmp-
Nano-L10. pSynAmp-Nano-L10 was linearized and injected into FVB zygotes
to generate SYN-NBL10 mice. See Extended Experimental Procedures for
details. Animals used in the study were male and female wild-type, SYN-
NBL10, p11-EGFP transgenic, or DAT-IRES-Cre knockin mice 10–20 weeks
old at the time of sacrifice. All mice were housed on a 12 hr light-dark schedule
and were sacrificed between the same circadian period (12:00–16:00).
Construction of AAV-FLEX-NBL10
NBL10 was PCR amplified from SYN-NBL10 genomic DNA with primers
adding a 50 HA epitope tag, along with restriction sites for subcloning into an
AAV vector. The PCR product was cloned in the reverse orientation into the
AscI and NheI sites of pAAV-EF1a-DIO-hChR2(H134R)-mCherry (Addgene
20297) generating pAAV-FLEX-NBL10. The plasmid was then sent to the
University of North Carolina Vector Core for AAV packaging with serotype 5.
Stereotaxic Surgeries
SYN-NBL10 transgenic, p11-EGFP, or wild-typemice 8–18 weeks of age were
induced and maintained on isofluorane anesthesia before being bilaterally
injected with 0.5 ml CAV-GFP or PRV-mCherry in the nucleus accumbens shell
(NAc, coordinates: ± 1.0 mmML, +1.35 mm AP, 4.2 mm DV). DAT-IRES-Cre
mice were injected in both the NAc with CAV-GFP, as well as the VTA with
AAV-FLEX-NBL10 (coordinates: ± 0.5 mm ML, 3.15 mm AP, 4.2 mm DV).
ML and AP coordinates are relative to bregma and DV coordinates are relative
to the pial surface. After viral injections, the needle was left in place for 10 min
before slowly retracting. The skin was closed with a surgical clip.
Immunohistochemistry
Brain sections were stained and mounted, followed by imaging on a Zeiss
LSM780 confocal microscope. Further details can be found in Extended
Experimental Procedures.
GFP Immunoprecipitations
Fourteen days after injections, mice were sacrificed and the ventral midbrain
and posterior hypothalamus were rapidly dissected on ice. Briefly, a 3 mm
slice was made approximately covering the region 1–4 mm posterior to
bregma. Lateral and dorsal parts were removed to isolate hypothalamus and
the ventral midbrain. Brains were then pooled into three groups of six mice
per group, homogenized in the presence of recombinant nanobody
(100 ng/ml, ChromoTek), and centrifuged to clarify. GFP Immunoprecipitation
was performed with two mouse monoclonal antibodies (19C8, 19F7; Doyle
et al., 2008). The resulting RNA was purified using the Absolutely RNA
Nanoprep Kit (Agilent) and analyzed using an Agilent 2100 Bioanalyzer,
followed by reverse transcription (QIAGEN QuantiTect) and Taqman qPCR.
Libraries for RNA-seq were prepared with oligo dT priming using the SMARTer
Ultra Low RNA Kit (Clontech) and analyzed on an Illumina HiSeq 2500. Further
details can be found in Extended Experimental Procedures.
Statistics
Transcript abundance estimates and differential expression tests for RNA-seq
data were performedwith cufflinks (cuffdiff). All other statistics were performed
in Prism GraphPad.
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